Curis Inc <CRIS.OQ> expected to post a loss of $1.36 a share - Earnings Preview
Curis Inc CRIS.OQ CRIS.O is expected to show a fall in quarterly revenue when it reports results on February 6 (estimated) for the period ending December 31 2024
The Lexington Massachusetts-based company is expected to report a 24.3% decrease in revenue to $2.04 million from $2.7 million a year ago, according to the mean estimate from 4 analysts, based on LSEG data.
LSEG's mean analyst estimate for Curis Inc is for a loss of $1.36 per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Curis Inc is $20.00, above its last closing price of $3.49.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Sep. 30 2024 | -1.83 | -1.17 | -1.70 | Missed | -45.3 |
Jun. 30 2024 | -1.64 | -1.67 | -2.03 | Missed | -21.3 |
Mar. 31 2024 | -2.12 | -2.12 | -2.05 | Beat | 3.4 |
Dec. 31 2023 | -2.11 | -2.11 | -2.03 | Beat | 4 |
Sep. 30 2023 | -2.33 | -2.33 | -2.13 | Beat | 8.4 |
Jun. 30 2023 | -2.38 | -2.36 | -2.40 | Missed | -1.7 |
Mar. 31 2023 | -1.98 | -2.08 | -2.40 | Missed | -15.4 |
Dec. 31 2022 | -2.60 | -2.40 | Beat | 7.7 |
This summary was machine generated February 4 at 13:02 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Related Articles
BHP’s 2025 Playbook: Turning Profit Dips into Strategic Wins
TradingKey - On August 18, 2025, BHP Group announced its full-year results for the 2025 fiscal year. Despite an 8% year-on-year revenue decline to $51.3 billion and a 26% significant drop in underlying attributable profit, which reflects core business performance, to $10.2 billion
U.S. Stock Market Risk Assessment: Learning from History, Mid-Term Outlook Remains Secure
We argue that the Federal Reserve’s monetary policy is the most critical factor influencing the stock market.
Powell's Jackson Hole Speech: For U.S. Stocks, Hawk or Dove Signal Could Be a Lose-Lose?
TradingKey - As U.S. inflation and labor market data show signs of rebalancing, Treasury traders and Wall Street banks have largely priced in a rate cut at the September FOMC meeting — the first of 2025. Yet both a more dovish-than-expected tone and a potential surprise hawkish signal from Fed Chair
Eurozone Q2 GDP Commentary: Will the Euro's Upward Momentum Persist?
TradingKey - On 14 August 2025, Eurostat published Q2 GDP figures, revealing a drop in the Eurozone's quarter-on-quarter growth from 0.6% in the first quarter to 0.1%. Consequently, annual growth eased from 1.5% to 1.4%. The slowdown primarily stems from the diminishing boost from European...
From Ozempic to Wegovy: Growth and Risks Behind Novo Nordisk’s Q2 Performance
TradingKey - Novo Nordisk achieved revenue of $11.67 billion in Q2 of the 2025 fiscal year, a 19% increase year-over-year, but it fell short of market expectations. Growth was primarily driven by strong performance in obesity care and rare diseases.
